Literature DB >> 6501564

Familial apolipoprotein AI and apolipoprotein CIII deficiency. Subclass distribution, composition, and morphology of lipoproteins in a disorder associated with premature atherosclerosis.

T M Forte, A V Nichols, R M Krauss, R A Norum.   

Abstract

Lipoprotein classes isolated from the plasma of two patients with apolipoprotein AI (apo AI) and apolipoprotein CIII (apo CIII) deficiency were characterized and compared with those of healthy, age- and sex-matched controls. The plasma triglyceride values for patients 1 and 2 were 31 and 51 mg/dl, respectively, and their cholesterol values were 130 and 122 mg/dl, respectively; the patients, however, had no measurable high density lipoprotein (HDL)-cholesterol. Analytic ultracentrifugation showed that patients' S degrees f 0-20 lipoproteins possess a single peak with S degrees f rates of 7.4 and 7.6 for patients 1 and 2, respectively, which is similar to that of the controls. The concentration of low density lipoprotein (LDL) (S degrees f 0-12) particles, although within normal range (331 and 343 mg/dl for patients 1 and 2, respectively), was 35% greater than that of controls. Intermediate density lipoproteins (IDL) and very low density lipoproteins (VLDL) (S degrees f 20-400) were extremely low in the patients. HDL in the patients had a calculated mass of 15.4 and 11.8 mg/dl for patients 1 and 2, respectively. No HDL could be detected by analytic ultracentrifugation, but polyacrylamide gradient gel electrophoresis (gge) revealed that patients possessed two major HDL subclasses: (HDL2b)gge at 11.0 nm and (HDL3b)gge at 7.8 nm. The major peak in the controls, (HDL3a)gge, was lacking in the patients. Gradient gel analysis of LDL indicated that patients' LDL possessed two peaks: a major one at 27 nm and a minor one at 26 nm. The electron microscopic structure of patients' lipoprotein fractions was indistinguishable from controls. Patients' HDL were spherical and contained a cholesteryl ester core, which suggests that lecithin/cholesterol acyltransferase was functional in the absence of apo AI. The effects of postprandial lipemia (100-g fat meal) were studied in patient 1. The major changes were the appearance of a 33-nm particle in the LDL density region of 1.036-1.041 g/ml and the presence of discoidal particles (12% of total particles) in the HDL region. The latter suggests that transformation of discs to spheres may be delayed in the patient. The simultaneous deficiency of apo AI and apo CIII suggests a dual defect in lipoprotein metabolism: one in triglyceride-rich lipoproteins and the other in HDL. The absence of apo CIII may result in accelerated catabolism of triglyceride-rich particles and an increased rate of LDL formation. Additionally, absence of apo CIII would favor rapid uptake of apo E-containing remnants by liver and peripheral cells. Excess cellular cholesterol would not be removed by the reverse cholesterol transport mechanism since HDL levels are exceedingly low and thus premature atherosclerosis occurs.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6501564      PMCID: PMC425337          DOI: 10.1172/JCI111576

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  42 in total

1.  Effect of the human plasma apolipoproteins and phosphatidylcholine acyl donor on the activity of lecithin: cholesterol acyltransferase.

Authors:  A K Soutar; C W Garner; H N Baker; J T Sparrow; R L Jackson; A M Gotto; L C Smith
Journal:  Biochemistry       Date:  1975-07-15       Impact factor: 3.162

2.  Isolation and characterization of an abnormal high density lipoprotein in Tangier Diesase.

Authors:  G Assmann; P N Herbert; D S Fredrickson; T Forte
Journal:  J Clin Invest       Date:  1977-07       Impact factor: 14.808

3.  Particle distribution of human serum high density lipoproteins.

Authors:  D W Anderson; A V Nichols; T M Forte; F T Lindgren
Journal:  Biochim Biophys Acta       Date:  1977-07-22

4.  Gradient gel electrophoresis of human plasma lipoproteins.

Authors:  G J Bautovich; M J Dash; W J Hensley; J R Turtle
Journal:  Clin Chem       Date:  1973-04       Impact factor: 8.327

Review 5.  The metabolic role of lecithin: cholesterol acyltransferase: perspectives form pathology.

Authors:  J A Glomset; K R Norum
Journal:  Adv Lipid Res       Date:  1973

6.  Inhibition of lipoprotein lipase by an apoprotein of human very low density lipoprotein.

Authors:  W V Brown; M L Baginsky
Journal:  Biochem Biophys Res Commun       Date:  1972-01-31       Impact factor: 3.575

7.  The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis.

Authors:  K Weber; M Osborn
Journal:  J Biol Chem       Date:  1969-08-25       Impact factor: 5.157

8.  The determination of total cholesterol in serum by gas-liquid chromatography compared with two other methods.

Authors:  F R Hindriks; B G Wolthers; A Groen
Journal:  Clin Chim Acta       Date:  1977-02-01       Impact factor: 3.786

9.  Plasma lipoproteins in familial lecithin: cholesterol acyltransferase deficiency: structure of low and high density lipoproteins as revealed by elctron microscopy.

Authors:  T Forte; K R Norum; J A Glomset; A V Nichols
Journal:  J Clin Invest       Date:  1971-05       Impact factor: 14.808

10.  Effects of lipoprotein lipase on the structure of chylomicrons.

Authors:  E J Blanchette-Mackie; R O Scow
Journal:  J Cell Biol       Date:  1973-09       Impact factor: 10.539

View more
  9 in total

1.  Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.

Authors:  H N Ginsberg; N A Le; I J Goldberg; J C Gibson; A Rubinstein; P Wang-Iverson; R Norum; W V Brown
Journal:  J Clin Invest       Date:  1986-11       Impact factor: 14.808

2.  Chylomicronemia due to apolipoprotein CIII overexpression in apolipoprotein E-null mice. Apolipoprotein CIII-induced hypertriglyceridemia is not mediated by effects on apolipoprotein E.

Authors:  T Ebara; R Ramakrishnan; G Steiner; N S Shachter
Journal:  J Clin Invest       Date:  1997-06-01       Impact factor: 14.808

3.  Clinical presentation, laboratory values, and coronary heart disease risk in marked high-density lipoprotein-deficiency states.

Authors:  Raul D Santos; Bela F Asztalos; Lilton R C Martinez; Marcio H Miname; Eliana Polisecki; Ernst J Schaefer
Journal:  J Clin Lipidol       Date:  2008-06-13       Impact factor: 4.766

4.  Sustained phenotypic correction in a mouse model of hypoalphalipoproteinemia with a helper-dependent adenovirus vector.

Authors:  K Oka; L M Belalcazar; C Dieker; E A Nour; P Nuno-Gonzalez; A Paul; S Cormier; J-K Shin; M Finegold; L Chan
Journal:  Gene Ther       Date:  2006-09-07       Impact factor: 5.250

5.  Genetic and phenotypic heterogeneity in familial lecithin: cholesterol acyltransferase (LCAT) deficiency. Six newly identified defective alleles further contribute to the structural heterogeneity in this disease.

Authors:  H Funke; A von Eckardstein; P H Pritchard; A E Hornby; H Wiebusch; C Motti; M R Hayden; C Dachet; B Jacotot; U Gerdes
Journal:  J Clin Invest       Date:  1993-02       Impact factor: 14.808

6.  Characterization of apolipoprotein A-I- and A-II-containing lipoproteins in a new case of high density lipoprotein deficiency resembling Tangier disease and their effects on intracellular cholesterol efflux.

Authors:  M C Cheung; A J Mendez; A C Wolf; R H Knopp
Journal:  J Clin Invest       Date:  1993-02       Impact factor: 14.808

7.  A frameshift mutation in the human apolipoprotein A-I gene causes high density lipoprotein deficiency, partial lecithin: cholesterol-acyltransferase deficiency, and corneal opacities.

Authors:  H Funke; A von Eckardstein; P H Pritchard; M Karas; J J Albers; G Assmann
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

Review 8.  High density lipoprotein cholesterol: an evolving target of therapy in the management of cardiovascular disease.

Authors:  Navin K Kapur; Dominique Ashen; Roger S Blumenthal
Journal:  Vasc Health Risk Manag       Date:  2008

9.  In Silico Analysis of Bioactive Peptides Released from Giant Grouper (Epinephelus lanceolatus) Roe Proteins Identified by Proteomics Approach.

Authors:  Fenny Crista A Panjaitan; Honey Lyn R Gomez; Yu-Wei Chang
Journal:  Molecules       Date:  2018-11-08       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.